Populix, an Indonesia-based market research tech startup, has netted USD 4.3 million in the first close of its Series B round ...

During the Web3 Festival in Hong Kong, H3 Entertainment is proud to announce a groundbreaking evolution in documentary ...

The ASX copped a big blow on Monday, falling by 1.6% and wiping out more than $30 billion in market value as concerns over ...

OLMo32B will be available via API as part of Vertex AI's model as a service (MaaS ... The fruitful translation of innovative research projects undertaken by scholars at Hong Kong Baptist University ...

Google Cloud’s latest enhancements to Vertex AI and the Gemini model family offer businesses a comprehensive solution for building, deploying, and managing AI applications with unprecedented ...

Vertex Pharmaceuticals saw a notable 20.53% share price increase over the last quarter, which coincided with several key developments in its Type 1 Diabetes (T1D) initiatives. The company ...

Zimislecel (VX-880) pivotal trial on track to complete enrollment and dosing in H1 2025; Vertex expects to submit marketing applications to global regulators in 2026 - Vertex has completed ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Hong Kong stocks were little changed on Wednesday, as investors held off on bets ahead of earnings from Tencent Holdings and a Federal Reserve meeting. The Hang Seng Index rose 0.1 per cent to ...

Hong Kong is channelling funds into several dozen innovative companies to further bolster the city’s appeal as a hub for technology, banking and finance compared with regional competitors like ...

Hong Kong has a free market economy, highly dependent on international trade and finance - the value of goods and services trade, including the sizable share of reexports, is about four times GDP.